Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
July 22, 1998
Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure
J R Piltz, R A Stone, S Boike, et al.
The Journal of Infectious Diseases
|
September 1, 1996
The pharmacokinetics, antigenicity, and fusion-inhibition activity of RSHZ19, a humanized monoclonal antibody to respiratory syncytial virus, in healthy volunteers
D E Everitt, C B Davis, K Thompson, et al.
The New England Journal of Medicine
|
July 16, 1992
A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes
J Avorn, S B Soumerai, D E Everitt, et al.
The Journal of Rheumatology
|
April 4, 2006
A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis
René Westhovens, Frédéric Houssiau, Johan Joly, et al.
Current Medical Research and Opinion
|
May 24, 2007
A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasis
Alice B Gottlieb, Kevin D Cooper, Thomas S McCormick, et al.
Journal of Clinical Pharmacology
|
November 1, 1994
Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers
M I Freed, P R Audet, N Zariffa, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 20, 2006
An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis
Eiko Toichi, Gisela Torres, Thomas S McCormick, et al.
The Journal of Investigative Dermatology
|
December 22, 2004
A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis
Catharine L Kauffman, Nancy Aria, Eiko Toichi, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1999
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease
H C Meissner, J R Groothuis, W J Rodriguez, et al.
Journal of Clinical Pharmacology
|
February 27, 2007
Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis
Honghui Zhou, Haishan Jang, Roy M Fleischmann, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
July 22, 1998
Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure
J R Piltz, R A Stone, S Boike, et al.
The Journal of Infectious Diseases
|
September 1, 1996
The pharmacokinetics, antigenicity, and fusion-inhibition activity of RSHZ19, a humanized monoclonal antibody to respiratory syncytial virus, in healthy volunteers
D E Everitt, C B Davis, K Thompson, et al.
The New England Journal of Medicine
|
July 16, 1992
A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes
J Avorn, S B Soumerai, D E Everitt, et al.
The Journal of Rheumatology
|
April 4, 2006
A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis
René Westhovens, Frédéric Houssiau, Johan Joly, et al.
Current Medical Research and Opinion
|
May 24, 2007
A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasis
Alice B Gottlieb, Kevin D Cooper, Thomas S McCormick, et al.
Journal of Clinical Pharmacology
|
November 1, 1994
Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers
M I Freed, P R Audet, N Zariffa, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 20, 2006
An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis
Eiko Toichi, Gisela Torres, Thomas S McCormick, et al.
The Journal of Investigative Dermatology
|
December 22, 2004
A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis
Catharine L Kauffman, Nancy Aria, Eiko Toichi, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1999
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease
H C Meissner, J R Groothuis, W J Rodriguez, et al.
Journal of Clinical Pharmacology
|
February 27, 2007
Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis
Honghui Zhou, Haishan Jang, Roy M Fleischmann, et al.
Page
of 9